The role of IL-10 in promoting disease progression in Leishmaniasis
Open accessAbstract
To determine the role of IL-10 in cutaneous leishmaniasis, we examined lesion development following Leishmania major infection of genetically susceptible BALB/c mice lacking IL-10. Whereas normal BALB/c mice developed progressive nonhealing lesions with numerous parasites within them, IL-10−/− BALB/c mice controlled disease progression, and had relatively small lesions with 1000-fold fewer parasites within them by the fifth week of infection. We also examined a mechanism whereby Leishmania induced the production of IL-10 from macrophages. We show that surface IgG on Leishmania amastigotes allows them to ligate Fcγ receptors on inflammatory macrophages to preferentially induce the production of high amounts of IL-10. The IL-10 produced by infected macrophages prevented macrophage activation and diminished their production of IL-12 and TNF-α. In vitro survival assays confirmed the importance of IL-10 in preventing parasite killing by activated macrophages. Pretreatment of monolayers with either rIL-10 or supernatants from amastigote-infected macrophages resulted in a dramatic enhancement in parasite intracellular survival. These studies indicate that amastigotes of Leishmania use an unusual and unexpected virulence factor, host IgG. This IgG allows amastigotes to exploit the antiinflammatory effects of FcγR ligation to induce the production of IL-10, which renders macrophages refractory to the activating effects of IFN-γ.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Infection of recruited inflammatory monocytes and resident macrophages can induce IL-10 secretion, which fosters the immunosuppressive environment observed in chronic infection.
“Infection of recruited inflammatory monocytes and resident macrophages can induce IL-10 secretion, which fosters the immunosuppressive environment observed in chronic infection (124, 125).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [125]
Cited by
Sorted by citations
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708 · see citing works
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591 · see citing works
Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10
Li, M. O., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.003 · Cited by 501 · see citing works
Dynamic and Transient Remodeling of the Macrophage IL-10 Promoter during Transcription
Zhang, X., Edwards, J. P., & Mosser, D. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1282 · Cited by 122 · see citing works
Self-citationArango Duque, G., Fukuda, M., Turco, S. J., Stäger, S., & Descoteaux, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303043 · Cited by 48 · see citing works
- Authors
- Kane, M. M., & Mosser, D. M.
- Affiliations
- Temple University (US)
- ORCID
- Mosser, David M
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01
- Volume
- 166
- Issue
- 2
- Pages
- 1141-1147
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1483961794
- Cited by
- 514
- References
- 0
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 17 · 2022: 18 · 2021: 18 · 2020: 19 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 17 · 2015: 21 · 2014: 18 · 2013: 24 · 2012: 24
- FWCI
- 31.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Temple University
- National Institute of Allergy and Infectious Diseases (AI 46805, AI24313, R01AI046805)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Keywords
- IL-10, cutaneous leishmaniasis, Leishmania major, amastigotes, macrophage activation, IL-12, TNF-α, parasite virulence factors, interferon-gamma, IL-10 knockout mice
- MeSH terms
- Adjuvants, Immunologic, Animals, Cell-Free System, Immunoglobulin G, Interferon-gamma, Lipopolysaccharides, Macrophage Activation, Macrophages, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Receptors, Antigen, B-Cell, Tumor Necrosis Factor-alpha, Interleukin-10, Leishmaniasis, Cutaneous, Leishmania major, Mice, Knockout, Disease Progression, Interleukin-12, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review